※ GFP bioresources Announcement of GFP bioresources
※ CRISPR/Cas9 genome edited bioresources Announcement of bioresources developed by the CRISPR/Cas9 technology:MTA（C-0065)
※ The 19 FPs owned or licensed by TBUSA Amendment to the license agreement between Takara Bio USA, Inc. and RIKEN BRC on preservation and distribution of Fluorescent Proteins for academic use
|Category||Order Form||Approval Form b)||Material Transfer Agreement a)
For use in research for not-for-profit academic purpose
For use in research for-profit-research purpose
How to write
|HEV||C-0047||-||C-0007 (2021.04.01)||C-0007p (2021.04.01)
|HSC||C-0049||-||C-0007 (2021.04.01)||C-0007p (2021.04.01)|
|GMC||C-0052||C-0006||C-0007 (2021.04.01)||C-0007p (2021.04.01)|
|AES||C-0032||C-0006||C-0007 (2021.04.01)||C-0007p (2021.04.01)
|APS||C-0033||C-0006||C-0007 (2021.04.01)||C-0007p (2021.04.01)
|C-0007 (2021.04.01)||C-0007p (2021.04.01)
|HES||C-0061 (2018.12.28)||-||C-0062 (2022.01.20)||C-0062 (2022.01.20)
- Category I MTA
For not-for-profit academic researches by not-for-profit institutions.
- Category II MTA
Applicable for the following use:
- By for-profit institutions.
- For collaborative researches by not-for-profit institutions with for-profit institutions.
- For contract researches by not-for-profit institutions financed by for-profit institutions.
- For researches by not-for-profit institutions for financial gain, including researches that directly aim to obtain patent.
b) In addition to Category I or II MTA, certain resources require prior written permission of the depositors.
When you outsource a part of works using our cell lines such as analysis of genes, analysis of differentiation potential, or generation of modified cell lines, an additional document is necessary in addition to the concluded MTA.
For such cases, please contact us prior to outsourcing a work.
Please send your form to the following address
|Cell Bank, RIKEN BioResource Research Center
3-1-1 Koyadai, Tsukuba, Ibaraki, 305-0074, Japan
E-mail : cellbank.brcriken.jp